Synonyms:Ixazomib, 1072833-77-2, MLN2238, MLN-2238, MLN 2238, (R)-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)boronic acid, (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid, Ixazomib (MLN2238), UNII-71050168A2, CHEMBL2141296, [(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]boronic acid, 71050168A2, [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid, Ixazomib [INN], Ixazomib [USAN:INN], Ixozamib, Ixazomib Impurity, Ixazomib (USAN), Ixazomib(MLN2238), MLN2238(Ixazomib), Ixazomib (MLN-2238), C14H19BCl2N2O4, GTPL8450, MLN-9708 FREE BASE, SCHEMBL3742758, CHEBI:90942, EX-A547, AMY19380, BCP02410, BCP24078, BDBM50398609, MFCD18251438, NSC766907, s2180, AKOS015995120, ZINC169946773, BCP9000953, CCG-264938, CS-1657, DB09570, NSC-766907, Boronic acid, b-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-, 1072833-77-2 (free), NCGC00249611-01, NCGC00249611-03, NCGC00249611-04, AC-28456, AS-55976, AT-42310, HY-10453, AB0033791, SW219743-1, X7547, J3.602.191H, A25328, D10130, J-001749, BRD-K78659596-001-01-3, Q20948663, 1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid, N-[(1R)-1-borono-3-methylbutyl]-N(2)-(2,5-dichlorobenzoyl)glycinamide, (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid;Ixazomib, [(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methyl-butyl]boronic acid, MLN-2238|||[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid
Id:25183872
Description:nan